Middle East

Trial begins of new UK COVID-19 treatment

Zaynab Khojji
article author: 
Wed, 2021-01-13 16:48

LONDON: A trial has begun in the UK of a new treatment to stop the development of severe symptoms in COVID-19 patients.
The treatment involves inhaling a protein called interferon beta, commonly used to treat multiple sclerosis, in order to stimulate the immune system before the virus can take hold.
Using a nebulizer, the drug is turned into a mist, making it easy to inhale, with each course currently costing around £2,000 ($2,733) to produce.

Main category: 

From Arab News

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button